Pieper Steven
See Remarks
Pieper Steven has filed 5 SEC Form 4 filings (10 transaction rows) across 1 company, with disclosures dating back to 2026. 5 of those filings fall inside the rolling window. Most recent filing: Sep 1, 2026.
On the most recent filing, Pieper Steven is listed as See Remarks at Xeris Biopharma Holdings, Inc. Inside the rolling window, Pieper Steven reported no open-market purchases and 4 open-market sales totaling $468K in XERS. The largest disclosed transaction in the window is a sale of 27,600 XERS shares on Jul 7, 2026, worth $235K.
Companies traded
Other insiders at XERS
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$468K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Pieper Steven made?
Pieper Steven has filed 5 SEC Form 4 filings (10 transaction rows) across 1 company since 2026.
Which companies does Pieper Steven trade?
Pieper Steven has filed SEC Form 4 disclosures for 1 company, including XERS.
When was Pieper Steven's most recent SEC Form 4 filing?
Pieper Steven's most recent SEC Form 4 filing on Tracefour is dated Sep 1, 2026.
What is Pieper Steven's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Pieper Steven is listed as See Remarks.
What is Pieper Steven's total buy and sell value in the current window?
Inside the rolling retention window, Pieper Steven bought $0 and sold $468K based on SEC Form 4 filings.
What was Pieper Steven's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 27,600 XERS shares on 2026-07-07, worth $235K, per SEC Form 4 filings.